Mayo Clinic Laboratory and Pathology Research Roundup: August 5

By Samantha Rossi • August 5, 2019

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for inducing and maintaining a complete or partial remission of proteinuria in patients with this condition. Via The New England Journal of Medicine.

Read more.

Published to PubMed This Week

• Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.
  New England Journal of Medicine
• Publisher Correction: On the Issue of Transparency and Reproducibility in Nanomedicine.
  Nature Nanotechnology
• The AMPK-Parkin Axis Negatively Regulates Necroptosis and Tumorigenesis by Inhibiting the Necrosome.
  Nature Cell Biology
• Impact of Concurrent Indolent Lymphoma on the Clinical Outcome of Newly Diagnosed Diffuse Large B-Cell Lymphoma.
  Blood
• LATE to the PART-y.
  Brain: A Journal of Neurology
• Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.
  Mayo Clinic Proceedings
• Exebacase in Addition to Daptomycin Is More Active Than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
  Antimicrobial Agents and Chemotherapy
• Antitumor Activity of Novel Pyrazole-Based Small Molecular Inhibitors of the STAT3 Pathway in Patient Derived High Grade Glioma Cells.
  PLoS One
• Immunoglobulin G4-Related Hepatobiliary Disease.
  Seminars in Diagnostic Pathology
• Relationship between Free Hemoglobin (Hemolysis), Potassium and Ionized Calcium in Lithium Heparin Blood Gas Samples Collected Intraoperatively.
  Clinical Biochemistry
• Update on the Classification of T-Cell Lymphomas, Hodgkin Lymphomas, and Histiocytic/Dendritic Cell Neoplasms.
  Expert Review of Hematology
• Long Term Outcomes of Patients with Low Grade Cystic Renal Epithelial Neoplasms.
  Urology
• Molecular Profiling of Long-Term IDH-Wildtype Glioblastoma Survivors.
  Neuro-Oncology
• Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma.
  Case Reports in Gastrointestinal Medicine

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.